Perrigo Nets Former Pharmacia Counsel Kingma To Support New Strategy
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's appointment of former Pharmacia associate general counsel Todd Kingma to VP and general counsel reflects the firm's recent expansion into generic Rx pharmaceuticals and bolsters its OTC patent defense team
You may also be interested in...
Loratadine Sales Keep Perrigo On Track To Meet Core Business Growth Goals
Perrigo expects to meet its fiscal 2004 target for core business growth despite continued delays in the approval of its 10 mg loratadine tablets (Schering-Plough's Claritin)
Loratadine Sales Keep Perrigo On Track To Meet Core Business Growth Goals
Perrigo expects to meet its fiscal 2004 target for core business growth despite continued delays in the approval of its 10 mg loratadine tablets (Schering-Plough's Claritin)
Loratadine Sales Keep Perrigo On Track To Meet Core Business Growth Goals
Perrigo expects to meet its fiscal 2004 target for core business growth despite continued delays in the approval of its 10 mg loratadine tablets (Schering-Plough's Claritin)